Scientists have published details regarding a protein which triggers hair loss raising hopes of developing a new cure for baldness. Writing in the Science Translational Medicine journal, researchers claim to have identified a protein which triggers hair loss in mice. More importantly the same protein has been identified in balding men.
“Essentially we showed that prostaglandin protein was elevated in the bald scalp of men and that it inhibited hair growth. So we identified a target for treating male pattern baldness, “ said Professor George Cotsarelis who led the research. “The next step would be to screen for compounds that affect this receptor and to also find out whether blocking that receptor would reverse balding or just prevent balding – a question that would take a while to figure out.”
What about treating male pattern balding now?
Although the new research raises hopes for finding new treatments for male pattern balding and receding hair lines, such a cure is still some time off. So far Professor Cotsarelis’ team have been unable to identify a compound which successfully inhibits the action of the protein in question, and even if they do, clinical trials will take several years before obtaining government approval.
Fortunately there are already clinically approved medications and other effective hair loss treatments which are proven to have a very high success rate when treating Androgenic Alopecia in both men and women. Therefore there is no reason for men experiencing hair loss to await the final outcomes of Professor Cotsarelis’ research before seeking treatment.
To find out more about how The Belgravia Centre treats Androgenic Alopecia and other hair loss conditions, please call us on 0800 077 6666 today, or message us at The Belgravia Centre to arrange a free, no obligation consultation with one of our hair loss experts.